NCT04459468View on ClinicalTrials.gov

Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

November 4, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

Lipiodol

Lipiodol TACE procedure

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER